United Therapeutics Corp. (UTHR) Pulmonologist Feedback on Tyvaso PH-ILD - Credit Suisse
Tweet Send to a Friend
Credit Suisse analyst Tiago Fauth reiterated an Outperform rating and $221.00 price target on United Therapeutics Corp. (NASDAQ: UTHR) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
